⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3090384 | 0.77 | — | — | |
| SCHEMBL151617 | 0.75 | — | — | |
| SCHEMBL348934 | 0.75 | — | — | |
| SCHEMBL1006106 | 0.75 | — | — | |
| SCHEMBL29773154 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL30837147 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL27927282 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL28316705 | 0.73 | HSP90AA1 (0.41) | — | |
| SCHEMBL23704165 | 0.71 | — | — | |
| SCHEMBL29994024 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3990417-B1 | IMPROVEMENTS IN AND RELATING TO NITRIFICATION INHIBITORS | LINCOLN UNIV (NZ) | 2024-03-27 | — | — | EP | claimed |
| CN-115867525-A | Improvements in and relating to nitrification inhibitors | 林肯大学 | 2023-03-28 | — | — | CN | claimed |
| EP-1768978-B1 | 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2008-07-09 | — | — | EP | claimed |
| EP-1177201-B1 | 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES | YAMASA CORP (JP) | 2003-09-24 | — | — | EP | claimed |
| US-6403568-B1 | FOR THERAPY OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) | YAMASA CORPORATION (JP) | 2002-06-11 | — | — | US | claimed |
| US-20020022722-A1 | 4'-C-ethynyl pyrimidine nucleoside compounds | OHRUI HIROSHI (JP) | 2002-02-21 | — | — | US | claimed |
| EP-1177201-A1 | 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES | YAMASA CORPORATION (JP) | 2002-02-06 | — | — | EP | claimed |
| WO-2000069876-A1 | 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES | YAMASA CORPORATION (JP) | 2000-11-23 | — | — | WO | claimed |
| US-20250122132-A1 | NITRIFICATION INHIBITORS | LINCOLN UNIVERSITY (NZ) | 2025-04-17 | — | — | US | disclosed |
| US-11970499-B1 | Pyrazolo[1,5-c]pyrimidine compounds as CK2 inhibitors | King Faisal University (SA) | 2024-04-30 | — | — | US | disclosed |
| EP-3990417-B1 | IMPROVEMENTS IN AND RELATING TO NITRIFICATION INHIBITORS | LINCOLN UNIV (NZ) | 2024-03-27 | — | — | EP | disclosed |
| EP-4339261-A2 | IMPROVEMENTS IN AND RELATING TO NITRIFICATION INHIBITORS | Lincoln University (NZ) | 2024-03-20 | — | — | EP | disclosed |
| US-20230339907-A1 | PROCESS FOR THE PREPARATION OF QUATERNIZED PYRIDAZINE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2023-10-26 | — | — | US | disclosed |
| US-20230339907-A1 | PROCESS FOR THE PREPARATION OF QUATERNIZED PYRIDAZINE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2023-10-26 | — | — | US | disclosed |
| US-6291670-B1 | VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS AND AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) | YAMASA CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| US-6291670-B1 | VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS AND AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) | YAMASA CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| US-6291670-B1 | VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS AND AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) | YAMASA CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| WO-2000069877-A1 | 4'-C-ETHYNYL PURINE NUCLEOSIDES | YAMASA CORPORATION (JP) | 2000-11-23 | — | — | WO | disclosed |
| WO-2000069876-A1 | 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES | YAMASA CORPORATION (JP) | 2000-11-23 | — | — | WO | disclosed |
| WO-2000069876-A1 | 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES | YAMASA CORPORATION (JP) | 2000-11-23 | — | — | WO | disclosed |